Canada - TSX:FTRP - CA31656R1029 - Common Stock
The current stock price of FTRP.CA is 3.74 CAD. In the past month the price decreased by -32%. In the past year, price decreased by -88.28%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
WELL-DB.CA | WELL HEALTH TECHNOLOGIES | N/A | 25.51B | ||
DNTL.CA | DENTALCORP HOLDINGS LTD | 25.93 | 2.08B | ||
AND.CA | ANDLAUER HEALTHCARE GROUP IN | 33.37 | 2.04B | ||
WELL.CA | WELL HEALTH TECHNOLOGIES COR | N/A | 1.32B | ||
AIDX.CA | HEALWELL AI INC | N/A | 392.28M | ||
QIPT.CA | QUIPT HOME MEDICAL CORP | N/A | 141.79M | ||
NLH.CA | NOVA LEAP HEALTH CORP | N/A | 25.32M | ||
NPTH.CA | NEUPATH HEALTH INC | N/A | 20.85M | ||
ARC.CA | ARCPOINT INC | 1.33 | 5.13M | ||
PHA.CA | PREMIER HEALTH OF AMERICA IN | N/A | 1.39M |
Field Trip Health Ltd. engages in development and delivery of technology-enabled psychedelic therapies. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-02-18. Through its Field Trip Discovery, it is engaged in developing psychedelic molecules and conducts research on plant-based psychedelics. Its Field Trip Health division operates clinics across North America and Europe providing ketamine-assisted psychotherapy (KAP) and therapies with other legal psychedelics under various programs. Its Field Trip Discovery division focuses on developing medicines targeting serotonin 5HT2A receptors. The company is conducting preclinical research into its first psychedelic molecule, FT-104, targeted for treatment resistant depression (TRD) and postpartum depression (PPD). The company is also exploring families of new chemical entity (NCE) structures, coined the FT-200 Group. Its Field Trip Digital division develops digital tools, such as the mobile application, Trip, and the patient application, Portal, to support and enhance patient outcomes and experience.
FIELD TRIP HEALTH LTD
30 Duncan Street, Suite 401
TORONTO ONTARIO CA
CEO: Joseph del Moral
Employees: 0
The current stock price of FTRP.CA is 3.74 CAD. The price increased by 7.16% in the last trading session.
The exchange symbol of FIELD TRIP HEALTH LTD is FTRP and it is listed on the Toronto Stock Exchange exchange.
FTRP.CA stock is listed on the Toronto Stock Exchange exchange.
9 analysts have analysed FTRP.CA and the average price target is 62.48 CAD. This implies a price increase of 1570.45% is expected in the next year compared to the current price of 3.74. Check the FIELD TRIP HEALTH LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
FIELD TRIP HEALTH LTD (FTRP.CA) has a market capitalization of 217.49M CAD. This makes FTRP.CA a Micro Cap stock.
FIELD TRIP HEALTH LTD (FTRP.CA) currently has 0 employees.
FIELD TRIP HEALTH LTD (FTRP.CA) has a resistance level at 5.11. Check the full technical report for a detailed analysis of FTRP.CA support and resistance levels.
The Revenue of FIELD TRIP HEALTH LTD (FTRP.CA) is expected to grow by 267.08% in the next year. Check the estimates tab for more information on the FTRP.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
FTRP.CA does not pay a dividend.
FIELD TRIP HEALTH LTD (FTRP.CA) will report earnings on 2022-02-15.
FIELD TRIP HEALTH LTD (FTRP.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.96).
ChartMill assigns a fundamental rating of 3 / 10 to FTRP.CA. The financial health of FTRP.CA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months FTRP.CA reported a non-GAAP Earnings per Share(EPS) of -0.96. The EPS decreased by -15.25% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -1125.3% | ||
ROA | -53.55% | ||
ROE | N/A | ||
Debt/Equity | 0.4 |
9 analysts have analysed FTRP.CA and the average price target is 62.48 CAD. This implies a price increase of 1570.45% is expected in the next year compared to the current price of 3.74.
For the next year, analysts expect an EPS growth of -20.59% and a revenue growth 267.08% for FTRP.CA